Stands on 2 placed sources from 1 publisher and 1 first-party instrument reading.
Hibiscus tea shows blood pressure benefits in new study AI illustrationhow this picture was madeA randomized crossover trial comparing hibiscus tea and coffee consumption before prolonged sitting has been published in the European Journal of Nutrition. The trial was indexed 6 November 2026 on PubMed and ClinicalTrials.gov [1].
The study enrolled 24 adult participants. Authors reported systolic blood pressure, diastolic blood pressure and mean arterial pressure were significantly lower in the hibiscus tea condition, by 4.2, 3.3 and 3.6 mmHg respectively. High frequency heart rate variability was also significantly higher for participants who consumed hibiscus tea.
All reported differences reached statistical significance at p < 0.05. No other significant differences in heart rate variability indices were detected. The authors declared no conflict of interest.
The European Journal of Nutrition also published a study on breast milk fatty acids and infant development led by Prof. Gao Ying on 31 October 2026 [2].
Proof2 sources · 2 publishers · signed
What this stands on
"Acute effects of hibiscus tea versus coffee consumption before prolonged sitting on blood pressure and heart rate variability in adults: a randomized crossover trial." published in European journal of nutrition as a randomized controlled trial (PubMed 42993332, doi 10.1007/s00394-026-04155-9). Sample: 24 as stated in the abstract. Results as the authors report them: SBP, DBP, and MAP were significantly lower ( = - 4.2, - 3.3, - 3.6 mmHg, respectively), and lnHF ( = 0.3) was significantly higher · PubMed and ClinicalTrials.gov, read by the New studies instrument · the fact record↗United Statesofficial source
A research team led by Prof. Gao Ying published a study on breast milk fatty acids and infant development in the European Journal of Nutrition on 31 October 2026. · Medical Xpress
Part of this reads PubMed and ClinicalTrials.gov, the public registries of published studies and registered trials directly. We could not place any of them by their address. None of the publishers is an official body: that part stands on reporting, not on the underlying document or transcript.